CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- FinancialsAltman Z-Score 3.25: safe zone
- Interpretations4 currently firing — 4
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.30%Above 5Y avg (2.04%)
Annual Rate
TRY 1.75Paid annual
Payout Ratio
57.4%Sustainable
Payback Period
43.4 yr
Last Ex-Dividend
May 6, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
52.11BTRY1.08B · vs all stocks (USD)
Revenue (TTM)
9.32BTRY194.03M · vs all stocks (USD)
Profit Margin
-24.83%Beta
0.2720xvs all stocks
52-Week Change
10.22%vs all stocks
Market Capitalization
52.11BTRY1.08B · vs all stocks (USD)
Enterprise Value
52.32BTRY1.09B · vs all stocks (USD)
Price to Sales (TTM)
5.57xPrice to Book (MRQ)
0.8515xEnterprise to Revenue
5.61xGross Margin
37.86%Profit Margin
-24.83%Operating Margin
-14.15%Return on Assets (TTM)
-0.66%Return on Equity (TTM)
-3.81%Revenue (TTM)
9.32BTRY194.03M · vs all stocks (USD)
Revenue per Share (TTM)
13.61TRYUpdated Aug 21, 2026Quarterly Revenue Growth
-18.50%Gross Profit (TTM)
3.56BTRY74.15M · vs all stocks (USD)
EBITDA (TTM)
1.71BTRY35.54M · vs all stocks (USD)
Net Income (TTM)
-2.32BTRY-48.19M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
29.17%Operating Cash Flow (TTM)
1.16BTRY24.20M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-619.16MTRY-12.88M · vs all stocks (USD)
Trailing Annual Dividend Rate
1.75TRYUpdated Aug 21, 2026Trailing Annual Dividend Yield
2.30%vs all stocks
5-Year Average Dividend Yield
2.04%vs all stocks
Payout Ratio
57.42%Minority Interest (Equity)
3.84MTRYFY2025 · Dec 31, 2025Revenue
9.87BTRYFY2025 · Dec 31, 2025Cost of Goods Sold
6.58BTRYFY2025 · Dec 31, 2025Gross Profit
3.29BTRYFY2025 · Dec 31, 2025Operating Income
-922.29MTRY-19.19M · vs all stocks (USD)
Pre-tax Income
2.98BTRYFY2025 · Dec 31, 2025Income Tax Expense
894.24MTRYFY2025 · Dec 31, 2025Net Income
2.09BTRYFY2025 · Dec 31, 2025EBIT
3.86BTRYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.71BTRYFY2025 · Dec 31, 2025Research & Development
79.13MTRYFY2025 · Dec 31, 2025Selling, General & Administrative
1.43BTRYFY2025 · Dec 31, 2025Other Operating Expenses
236.96MTRYFY2025 · Dec 31, 2025Non-operating Interest Income
1.09BTRYFY2025 · Dec 31, 2025Non-operating Interest Expense
880.61MTRYFY2025 · Dec 31, 2025Net Income from Continuing Operations
2.09BTRYFY2025 · Dec 31, 2025Minority Interests (P&L)
946.00KTRYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00TRYFY2025 · Dec 31, 2025Operating Cash Flow
3.82BTRYFY2025 · Dec 31, 2025Free Cash Flow
3.78BTRYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
4.52BTRYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
2.09BTRYFY2025 · Dec 31, 2025Other Non-cash Items
929.85MTRYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
516.06MTRYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
290.31MTRYFY2025 · Dec 31, 2025Capital Expenditures
-39.30MTRYFY2025 · Dec 31, 2025Other Investing Activity
3.49BTRYFY2025 · Dec 31, 2025Net Investing Cash Flow
3.45BTRYFY2025 · Dec 31, 2025Long-term Debt Issuance
722.36MTRYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.47BTRYFY2025 · Dec 31, 2025Common Dividends Paid
-1.36BTRYFY2025 · Dec 31, 2025Other Financing Charges
545.03MTRYFY2025 · Dec 31, 2025Net Financing Cash Flow
-1.57BTRYFY2025 · Dec 31, 2025Shares Outstanding
685.26MSharesUpdated Aug 21, 2026Float Shares
151.11MSharesUpdated Aug 21, 2026% Held by Insiders
77.95%vs all stocks
% Held by Institutions
1.36%vs all stocks
Total Cash (MRQ)
2.49BTRY51.80M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.63TRYUpdated Aug 21, 2026Total Debt (MRQ)
3.95BTRY82.29M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0575xCurrent Ratio (MRQ)
1.47xBook Value per Share (MRQ)
89.08TRYUpdated Aug 21, 2026Total Assets
75.00BTRY1.56B · vs all stocks (USD)
Total Current Assets
9.67BTRYFY2025 · Dec 31, 2025Total Liabilities
13.96BTRYFY2025 · Dec 31, 2025Total Non-current Assets
65.33BTRYFY2025 · Dec 31, 2025Total Non-current Liabilities
9.14BTRYFY2025 · Dec 31, 2025Total Current Liabilities
4.82BTRYFY2025 · Dec 31, 2025Cash
36.65MTRYFY2025 · Dec 31, 2025Cash Equivalents
4.49BTRYFY2025 · Dec 31, 2025Cash & Cash Equivalents
4.53BTRYFY2025 · Dec 31, 2025Other Short-term Investments
322.78MTRYFY2025 · Dec 31, 2025Accounts Receivable
2.27BTRYFY2025 · Dec 31, 2025Inventory
2.16BTRYFY2025 · Dec 31, 2025Accounts Payable
1.87BTRYFY2025 · Dec 31, 2025Short-term Debt
2.11BTRYFY2025 · Dec 31, 2025Other Current Liabilities
18.36MTRYFY2025 · Dec 31, 2025Long-term Debt
1.05BTRYFY2025 · Dec 31, 2025Common Stock (Book)
685.26MTRYFY2025 · Dec 31, 2025Retained Earnings
35.25BTRYFY2025 · Dec 31, 2025Total Shareholders' Equity
61.04BTRY1.27B · vs all stocks (USD)
52-Week Low
53.45TRYUpdated Aug 21, 202652-Week High
132.60TRYUpdated Aug 21, 202652-Week Change
10.22%vs all stocks
Beta
0.2720xvs all stocks
50-Day MA
75.26TRYUpdated Aug 21, 2026200-Day MA
93.29TRYUpdated Aug 21, 2026Avg 10-Day Volume
4.80MSharesUpdated Aug 21, 2026Avg 30-Day Volume
3.70MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
-3.38TRYUpdated Aug 21, 20264 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Multi-Year Cash Increase With FCF And Debt Decrease
Cash up four years running while long-term debt fell for three.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
How is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Drawdown With FCF And Cash Backing
Well below its peak, with three years of positive free cash flow behind it.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.25: safe zoneNotable
Altman Z-Score: 3.25
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Cullinan Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Jiangsu Kanion Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Lifetech Scientific Corporation
Tier 1ProductionApproval-Gated PipelineRule
Procept BioRobotics Corporation
Tier 1ProductionApproval-Gated PipelineRule
Dezhan Health Care Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Changchun BCHT Biotechnology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Orum Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Beijing Sun-Novo Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Anhui Wanbang Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Star Lake Bioscience Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Tyler Technologies Inc.
3 interpretationsDrawdown With FCF And Cash BackingMulti-Year Revenue, Profit, And Income GrowthClose Below 40W SMA With Profitability
Boston Scientific Corporation
3 interpretationsDrawdown With FCF And Cash BackingMulti-Year Revenue, Profit, And Income GrowthClose Below 40W SMA With Profitability
Fortune Electric Co., Ltd.
3 interpretationsDrawdown With FCF And Cash BackingMulti-Year Revenue, Profit, And Income GrowthClose Below 40W SMA With Profitability